• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to 2-(2,6-difluoro-4-methoxyphenyl)acetic acid (CAS No. 886498-98-2) and Its Emerging Applications in Chemical Biology

2-(2,6-difluoro-4-methoxyphenyl)acetic acid, identified by the chemical identifier CAS No. 886498-98-2, is a specialized organic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural motifs—including a difluorobenzene ring and a methoxy substituent—holds promise for its potential applications in drug discovery and molecular interactions. The presence of both fluoro and methoxy groups imparts distinct electronic and steric properties, making it a valuable scaffold for designing novel bioactive molecules.

The structural framework of 2-(2,6-difluoro-4-methoxyphenyl)acetic acid positions it as a candidate for further exploration in medicinal chemistry. The difluorobenzene moiety is particularly noteworthy, as fluorine atoms are frequently incorporated into pharmaceuticals to enhance metabolic stability, binding affinity, and overall pharmacological efficacy. In contrast, the methoxy group contributes to hydrophobicity and can influence molecular recognition processes. Together, these substituents create a balance that may facilitate interactions with biological targets, such as enzymes or receptors.

Recent advancements in computational chemistry have enabled the systematic screening of such compounds for their biological activity. Researchers have leveraged machine learning models to predict the binding affinity of 2-(2,6-difluoro-4-methoxyphenyl)acetic acid to various protein targets. Preliminary simulations suggest that this compound may exhibit inhibitory effects on certain kinases or transcription factors, which are implicated in diseases like cancer and inflammation. These findings align with the broader trend of utilizing structurally diverse compounds to modulate complex biological pathways.

In vitro studies have begun to elucidate the mechanistic aspects of 2-(2,6-difluoro-4-methoxyphenyl)acetic acid. For instance, its interaction with cytochrome P450 enzymes has been investigated to assess potential drug-drug interactions. The electron-withdrawing nature of the difluorobenzene ring may influence redox processes, while the carboxylic acid functionality provides a site for hydrogen bonding or salt formation with biological partners. Such properties make it an intriguing candidate for further biochemical characterization.

The pharmaceutical industry has shown increasing interest in fluorinated aromatic compounds due to their enhanced bioavailability and resistance to enzymatic degradation. 2-(2,6-difluoro-4-methoxyphenyl)acetic acid exemplifies this trend, as its structural features are designed to optimize pharmacokinetic profiles. Additionally, its acetic acid derivative offers versatility in medicinal chemistry transformations, such as amidation or esterification, which can further tailor its biological activity.

Emerging research also highlights the role of this compound in modulating inflammatory pathways. The combination of fluoro and methoxy substituents may disrupt signaling cascades associated with chronic inflammation, such as NF-κB or MAPK pathways. Experimental data from cell-based assays indicate that derivatives of this scaffold could serve as leads for anti-inflammatory therapies. This aligns with global efforts to develop more selective and less toxic alternatives to existing treatments.

The synthesis of 2-(2,6-difluoro-4-methoxyphenyl)acetic acid presents both challenges and opportunities for synthetic chemists. Traditional methods often involve multi-step sequences involving halogenation and functional group transformations. However, recent innovations in catalytic processes have enabled more efficient routes to fluorinated aromatics, reducing reliance on hazardous reagents. Such advancements not only improve scalability but also align with green chemistry principles by minimizing waste generation.

Future directions for this compound include exploring its role in epigenetic modulation. The aromatic ring system combined with polar functional groups makes it a plausible candidate for interacting with histone deacetylases or other epigenetic enzymes. Preliminary data suggest that modifications at the carboxylic acid or aromatic positions could enhance binding specificity without compromising solubility or bioavailability.

The broader implications of compounds like 2-(2,6-difluoro-4-methoxyphenyl)acetic acid extend beyond academic research into industrial applications. Pharmaceutical companies are increasingly investing in libraries of structurally diverse molecules for high-throughput screening (HTS). This compound’s unique features make it a valuable addition to such libraries, potentially accelerating the discovery of novel therapeutics across multiple therapeutic areas.

In conclusion,2-(2,6-difluoro-4-methoxyphenyl)acetic acid (CAS No. 886498-98-2) represents a promising entity in chemical biology and drug development. Its structural attributes—particularly the interplay between the difluorobenzene, methoxy, and carboxylic acid functionalities—offer multiple avenues for therapeutic intervention. As research progresses, this compound is likely to play an increasingly significant role in addressing unmet medical needs through innovative molecular design and interdisciplinary collaboration.

• 68886-07-7(2-(2-fluoro-4-hydroxyphenyl)acetic acid)
• 886499-32-7((2,4-difluoro-3-methoxyphenyl)acetic Acid)
• 1017779-16-6(2,6-Difluoro-4-ethoxyphenylacetic acid)
• 107610-23-1(Benzeneacetic acid,2-(fluoro-18F)-4-hydroxy-5-methoxy- (9CI))
• 883531-28-0(2-(2-fluoro-4-methoxyphenyl)acetic acid)
• 798563-50-5(2-(2-Fluoro-5-methoxyphenyl)acetic acid)
• 1268822-63-4(2-(2,6-difluoro-4-methoxyphenyl)malonic acid)
• 91407-50-0(BENZENEACETIC ACID, 2-FLUORO-4,5-DIMETHOXY-)
• 500912-19-6(2-(2-fluoro-6-methoxyphenyl)acetic acid)
• 886498-65-3(2,6-Difluoro-3-methoxyphenylacetic acid)